Drug Type Small molecule drug |
Synonyms AD-102 |
Target |
Action modulators, agonists |
Mechanism ERs modulators(Estrogen receptors modulators), VDR agonists(Vitamin D receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC28H28ClNO4S |
InChIKeyBKXVVCILCIUCLG-UHFFFAOYSA-N |
CAS Registry82640-04-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoporosis | Phase 1 | United States | 28 Feb 2019 | |
Osteoporosis, Postmenopausal | Phase 1 | South Korea | - |
Phase 3 | 460 | (Control 400 IU Vitamin D3) | ghljfnacat(sweithyvzd) = pmxrephekl jlvkvwmdfa (qsbnkjinge, 11.5) View more | - | 03 Jun 2016 | ||
(2400 IU Vitamin D3 (Cholecalciferol)) | ghljfnacat(sweithyvzd) = mkrtcvfbza jlvkvwmdfa (qsbnkjinge, 55.6) View more |